Goldman Sachs Group Inc Teva Pharmaceutical Industries LTD Transaction History

Goldman Sachs Group Inc

  • $780 Billion
  • Q3 2025

A detailed history of Goldman Sachs Group Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Goldman Sachs Group Inc holds 3,372,200 shares of TEVA stock, worth $85.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,372,200
Previous 4,882,794 30.94%
Holding current value
$85.7 Million
Previous $81.8 Million 16.76%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$15.38 - $20.2 $3.12 Million - $4.1 Million
202,825 Added 4.15%
5,085,619 $103 Million
Q2 2025

Aug 14, 2025
BUY
$12.82 - $18.15 $11.8 Million - $16.7 Million
917,537 Added 23.14%
4,882,794 $81.8 Million
Q1 2025

May 16, 2025
SELL
$14.67 - $22.01 $94.1 Million - $141 Million
-6,411,300 Reduced 61.79%
3,965,257 $60.9 Million
Q1 2025

May 09, 2025
BUY
$14.67 - $22.01 $101 Million - $151 Million
6,859,718 Added 195.05%
10,376,557 $159 Million
Q4 2024

Feb 11, 2025
SELL
$16.43 - $22.77 $10.5 Million - $14.6 Million
-641,489 Reduced 15.43%
3,516,839 $77.5 Million
Q3 2024

Nov 14, 2024
SELL
$15.81 - $18.96 $2.09 Million - $2.51 Million
-132,319 Reduced 3.08%
4,158,328 $74.9 Million
Q2 2024

Aug 13, 2024
BUY
$12.78 - $17.4 $9.54 Million - $13 Million
746,787 Added 21.07%
4,290,647 $69.7 Million
Q1 2024

May 15, 2024
SELL
$10.67 - $14.43 $2.79 Million - $3.77 Million
-261,488 Reduced 6.87%
3,543,860 $50 Million
Q4 2023

Feb 13, 2024
SELL
$8.12 - $10.63 $5.15 Million - $6.74 Million
-633,945 Reduced 14.28%
3,805,348 $39.7 Million
Q3 2023

May 14, 2024
BUY
$7.48 - $10.7 $4.74 Million - $6.78 Million
633,945 Added 16.66%
4,439,293 $45.3 Million
Q3 2023

Nov 14, 2023
SELL
$7.48 - $10.7 $826,839 - $1.18 Million
-110,540 Reduced 2.43%
4,439,293 $45.3 Million
Q2 2023

May 14, 2024
SELL
$7.2 - $9.47 $758,001 - $996,982
-105,278 Reduced 2.26%
4,549,833 $34.3 Million
Q2 2023

Aug 14, 2023
SELL
$7.2 - $9.47 $758,001 - $996,982
-105,278 Reduced 2.26%
4,549,833 $34.3 Million
Q1 2023

May 14, 2024
SELL
$8.36 - $11.37 $5.71 Million - $7.77 Million
-683,033 Reduced 12.8%
4,655,111 $41.2 Million
Q1 2023

May 11, 2023
SELL
$8.36 - $11.37 $5.71 Million - $7.77 Million
-683,033 Reduced 12.8%
4,655,111 $41.2 Million
Q4 2022

May 14, 2024
BUY
$7.95 - $9.48 $945,883 - $1.13 Million
118,979 Added 2.28%
5,338,144 $48.7 Million
Q4 2022

Feb 13, 2023
BUY
$7.95 - $9.48 $945,883 - $1.13 Million
118,979 Added 2.28%
5,338,144 $48.7 Million
Q3 2022

May 14, 2024
BUY
$6.86 - $11.95 $2.75 Million - $4.78 Million
400,197 Added 8.3%
5,219,165 $42.1 Million
Q3 2022

Nov 10, 2022
BUY
$6.86 - $11.95 $2.75 Million - $4.78 Million
400,197 Added 8.3%
5,219,165 $42.1 Million
Q2 2022

May 14, 2024
BUY
$7.38 - $10.4 $7.48 Million - $10.5 Million
1,013,620 Added 26.64%
4,818,968 $36.2 Million
Q2 2022

Aug 15, 2022
BUY
$7.38 - $10.4 $10.5 Million - $14.8 Million
1,425,393 Added 42.0%
4,818,968 $36.2 Million
Q1 2022

May 16, 2022
SELL
$7.33 - $9.39 $5.17 Million - $6.63 Million
-705,599 Reduced 17.21%
3,393,575 $31.9 Million
Q4 2021

Feb 14, 2022
BUY
$7.9 - $10.19 $6.62 Million - $8.54 Million
837,955 Added 25.69%
4,099,174 $32.8 Million
Q3 2021

Nov 10, 2021
BUY
$8.38 - $10.18 $27.3 Million - $33.2 Million
3,261,219 New
3,261,219 $31.8 Million

Others Institutions Holding TEVA

# of Institutions
669
Shares Held
623M
Call Options Held
30.8M
Put Options Held
18.5M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $28.2B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email